• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.

作者信息

Yoon S, Schmassmann-Suhijar D, Zuber M, Konietzny P, Schmassmann A

出版信息

Ann Oncol. 2006 Dec;17(12):1851-2. doi: 10.1093/annonc/mdl140. Epub 2006 Jun 15.

DOI:10.1093/annonc/mdl140
PMID:16777923
Abstract
摘要

相似文献

1
Chemotherapy with bevacizumab, irinotecan, 5-fluorouracil and leucovorin (IFL) associated with a large, embolizing thrombus in the thoracic aorta.使用贝伐单抗、伊立替康、5-氟尿嘧啶和亚叶酸钙（IFL）进行化疗，伴有胸主动脉内一个巨大的、有栓子形成的血栓。
Ann Oncol. 2006 Dec;17(12):1851-2. doi: 10.1093/annonc/mdl140. Epub 2006 Jun 15.
2
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.贝伐单抗联合伊立替康、氟尿嘧啶和亚叶酸钙治疗转移性结直肠癌。
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
3
A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200.一项关于高剂量贝伐单抗联合伊立替康、5-氟尿嘧啶、亚叶酸钙作为晚期结直肠癌初始治疗的II期研究：东部肿瘤协作组E2200研究结果
Ann Oncol. 2006 Sep;17(9):1399-403. doi: 10.1093/annonc/mdl161. Epub 2006 Jul 27.
4
Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer.一名接受过多次治疗的转移性结肠癌患者在接受含伊立替康/5-氟尿嘧啶/亚叶酸钙/贝伐单抗治疗后发生致命性肿瘤溶解综合征。
Acta Oncol. 2008;47(1):155-6. doi: 10.1080/02841860701460533.
5
[Evaluation of bevacizumab combined with irinotecan-based regimen as the first-line treatment for patients with metastatic colorectal cancer].贝伐单抗联合以伊立替康为基础的方案作为转移性结直肠癌患者一线治疗的评估
Zhonghua Zhong Liu Za Zhi. 2010 Oct;32(10):786-90.
6
Efficient and safe application of a FOLFIRI/bevacizumab combination to a patient with locally advanced rectal cancer and severe chronic renal failure.
Onkologie. 2007 Feb;30(1-2):65. doi: 10.1159/000098704. Epub 2007 Jan 26.
7
[A case of advanced rectal carcinoma with multiple lung metastases responding to irinotecan combined with 5-fluorouracil and l-leucovorin (IFL) as neoadjuvant chemotherapy (NAC)].
Gan To Kagaku Ryoho. 2006 Nov;33(11):1665-8.
8
Phase IV study of bevacizumab in combination with infusional fluorouracil, leucovorin and irinotecan (FOLFIRI) in first-line metastatic colorectal cancer.贝伐单抗联合氟尿嘧啶持续静脉滴注、亚叶酸钙和伊立替康（FOLFIRI）用于一线转移性结直肠癌的IV期研究。
Oncology. 2009;77(2):113-9. doi: 10.1159/000229787. Epub 2009 Jul 23.
9
Bevacizumab in colorectal cancer.贝伐单抗用于结直肠癌治疗
N Engl J Med. 2004 Oct 14;351(16):1690-1; author reply 1690-1.
10
[Up to date chemotherapy for colon cancer].[最新的结肠癌化疗方法]
Nihon Shokakibyo Gakkai Zasshi. 2007 Feb;104(2):177-85.

引用本文的文献

1
Management Strategies for Descending Thoracic Aortic Thrombus: A Review of the Literature.降主动脉血栓管理策略：文献回顾。
Innovations (Phila). 2022 Jul-Aug;17(4):283-296. doi: 10.1177/15569845221107011. Epub 2022 Jul 21.
2
Bevacizumab-induced Aortic Arterial Thrombosis.贝伐单抗诱导的主动脉血栓形成。
Intern Med. 2018 Oct 15;57(20):2987-2990. doi: 10.2169/internalmedicine.0209-17. Epub 2018 May 18.
3
The incidence and predictors of thromboembolic events in patients with lung cancer.肺癌患者血栓栓塞事件的发生率及预测因素
ScientificWorldJournal. 2014 Jan 20;2014:125706. doi: 10.1155/2014/125706. eCollection 2014.
4
Unilateral renal artery stenosis with renal atrophy in a patient with metastatic papillary thyroid carcinoma treated with sorafenib.索拉非尼治疗的转移性乳头状甲状腺癌患者出现单侧肾动脉狭窄伴肾萎缩。
BMJ Case Rep. 2013 May 15;2013:bcr2013009898. doi: 10.1136/bcr-2013-009898.
5
Roles for VEGF in the adult.血管内皮生长因子在成体中的作用。
Microvasc Res. 2007 Sep-Nov;74(2-3):100-13. doi: 10.1016/j.mvr.2007.03.004. Epub 2007 Apr 6.